Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Retisert receives FDA approval

April 13, 2005

No Comments

Bausch & Lomb discloses new therapeutic agents for ophthalmic diseases

April 13, 2005

No Comments

Japanese licensing agreement for Posurdex

April 1, 2005

No Comments

Highlights of the 15th Annual Meeting of the American Glaucoma Society

March 30, 2005

No Comments

FDA approval for Xibrom

March 30, 2005

No Comments

CAT terminates further glaucoma development of Trabio

March 24, 2005

No Comments

ISTA submits IND for phase IIb study of ecabet sodium for dry eye syndrome

March 23, 2005

No Comments

IND accepted for clinical testing of Moli-1901 for dry eye syndrome

March 18, 2005

No Comments

Miravant plans confirmatory phase III study for Photrex

March 17, 2005

No Comments

Avastin shows promise for wet AMD

March 14, 2005

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Retisert receives FDA approval

Bausch & Lomb discloses new therapeutic agents for ophthalmic diseases

Japanese licensing agreement for Posurdex

Highlights of the 15th Annual Meeting of the American Glaucoma Society

FDA approval for Xibrom

CAT terminates further glaucoma development of Trabio

ISTA submits IND for phase IIb study of ecabet sodium for dry eye syndrome

IND accepted for clinical testing of Moli-1901 for dry eye syndrome

Miravant plans confirmatory phase III study for Photrex

Avastin shows promise for wet AMD

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Ocular RSS

Ocular
RSS